FIGURE
Fig. 5
- ID
- ZDB-FIG-220804-23
- Publication
- Delnoy et al., 2022 - Novel mRNA therapy restores GALT protein and enzyme activity in a zebrafish model of classical galactosemia
- Other Figures
- All Figure Page
- Back to All Figure Page
Fig. 5
Galactose (100 mM) exposure: survival rates in 5 dpf CG zebrafish (galt KO) following single dose intravenous hGALT injection (100 ng/μl). Total sample size at the start of galactose exposure can be found in Table S2, results are presented as survival rate ± 95% CI. WT, wildtype; NIC, non-injected CG zebrafish (galt KO) control; LNP2, LNP2-packaged hGALT mRNA injected CG zebrafish (galt KO)
|
Expression Data
Expression Detail
Antibody Labeling
Phenotype Data
| Fish: | |
|---|---|
| Condition: | |
| Observed In: | |
| Stage: | Day 5 |
Phenotype Detail
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and
ZFIN has permission only to display this image to its users.
Additional permissions should be obtained from the applicable author or publisher of the image.
Full text @ J. Inherit. Metab. Dis.